India  

World Health Organization Halts Trials Of Hydroxychloroquine

Video Credit: Wochit - Duration: 00:38s - Published
World Health Organization Halts Trials Of Hydroxychloroquine

World Health Organization Halts Trials Of Hydroxychloroquine

The World Health Organization announced they are temporarily suspending clinical trials of hydroxychloroquine.

The controversial drug has been used as an experimental coronavirus treatment for the past several months.

Now, amid mounting safety concerns experts are ending all clinical trials involving the medication.

According to Gizmodo, testing for hydroxychloroquine has been halted pending a safety assessment.

A recent study has linked the drug to an increased risk of death and heart conditions among COVID-19 patients.

U.S. President Donald Trump announced last week that he has been taking the drug for nearly 2 weeks as a preventative.

There is no data that supports Hydroxychloroquine is a preventive medication for COVID-19.


You Might Like

Related news from verified sources

Factbox: Key upcoming clinical trials of hydroxychloroquine, touted by Trump, for COVID-19

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19...
Reuters India - Published

Covid: WHO suspends hydroxychloroquine trial

The World Health Organization said Monday that it had "temporarily" suspended clinical trials of...
IndiaTimes - Published


Related videos from verified sources

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 [Video]

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19

The move comes after a report linked the drug to an increased fatality rate among those with coronavirus.

Credit: Cover Video STUDIO     Duration: 01:29Published
France Rejected hydroxychloroquine For Covid Patients [Video]

France Rejected hydroxychloroquine For Covid Patients

France Rejected hydroxychloroquine For Covid Patients

Credit: Wochit Business     Duration: 00:25Published
COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials [Video]

COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

While commenting on World Health Organisation's decision to temporarily suspend clinical trials of hydroxychloroquine, Director General of Council of Scientific and Industrial Research (CSIR), Shekhar..

Credit: ANI     Duration: 01:43Published